Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |